M Alander

Summary

Affiliation: VTT Biotechnology
Country: Finland

Publications

  1. ncbi Beta-lactamase production in Prevotella intermedia, Prevotella nigrescens, and Prevotella pallens genotypes and in vitro susceptibilities to selected antimicrobial agents
    J Mättö
    Research Laboratory, Institute of Dentistry, University of Helsinki, Helsinki, Finland
    Antimicrob Agents Chemother 43:2383-8. 1999
  2. ncbi Genetic heterogeneity and functional properties of intestinal bifidobacteria
    J Mättö
    VTT Biotechnology, Espoo, Finland
    J Appl Microbiol 97:459-70. 2004
  3. ncbi Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in IBS and control subjects
    Jaana Mättö
    VTT Biotechnology, Finland
    FEMS Immunol Med Microbiol 43:213-22. 2005
  4. ncbi Comparison of three test media for antimicrobial susceptibility testing of bifidobacteria using the Etest method
    J Mättö
    VTT Technical Research Centre of Finland, P O Box 1000, FI 02044 VTT, Espoo, Finland
    Int J Antimicrob Agents 28:42-8. 2006
  5. ncbi The effect of probiotic strains on the microbiota of the Simulator of the Human Intestinal Microbial Ecosystem (SHIME)
    M Alander
    VTT Biotechnology and Food Research, Finland
    Int J Food Microbiol 46:71-9. 1999

Collaborators

  • M L Suihko
  • S M Finegold
  • S Asikainen
  • J Mättö
  • M Saarela
  • Jaana Mättö
  • Riitta Korpela
  • Airi Palva
  • Kajsa Kajander
  • Liisa Maunuksela
  • Anna Kassinen
  • Maria Saarela
  • E Malinen
  • A Palva
  • H Jousimies-Somer
  • K Salminen
  • E Kononen
  • B Von Troil-Lindén
  • M L Vaisanen

Detail Information

Publications5

  1. ncbi Beta-lactamase production in Prevotella intermedia, Prevotella nigrescens, and Prevotella pallens genotypes and in vitro susceptibilities to selected antimicrobial agents
    J Mättö
    Research Laboratory, Institute of Dentistry, University of Helsinki, Helsinki, Finland
    Antimicrob Agents Chemother 43:2383-8. 1999
    ..The MICs of amoxicillin-clavulanate and cefoxitin were relatively higher for the beta-lactamase-positive population than for the beta-lactamase-negative population...
  2. ncbi Genetic heterogeneity and functional properties of intestinal bifidobacteria
    J Mättö
    VTT Biotechnology, Espoo, Finland
    J Appl Microbiol 97:459-70. 2004
    ....
  3. ncbi Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in IBS and control subjects
    Jaana Mättö
    VTT Biotechnology, Finland
    FEMS Immunol Med Microbiol 43:213-22. 2005
    ..The present study suggests that instability of intestinal microbiota may be involved in IBS. However, further studies are needed to associate the instability with specific IBS symptoms or with specific bacterial groups and species...
  4. ncbi Comparison of three test media for antimicrobial susceptibility testing of bifidobacteria using the Etest method
    J Mättö
    VTT Technical Research Centre of Finland, P O Box 1000, FI 02044 VTT, Espoo, Finland
    Int J Antimicrob Agents 28:42-8. 2006
    ..This study describes test medium-dependent variation of MICs and the applicability of LSM+cys for antimicrobial susceptibility testing of bifidobacteria...
  5. ncbi The effect of probiotic strains on the microbiota of the Simulator of the Human Intestinal Microbial Ecosystem (SHIME)
    M Alander
    VTT Biotechnology and Food Research, Finland
    Int J Food Microbiol 46:71-9. 1999
    ..This pattern was similar in the reactors representing both the small and large intestine in the model. The changes in short-chain fatty acids were small, and no definite trend was observed...